Directory
Andree Yeramian Hakim

Andree Yeramian Hakim

Degree: PhD

973 70 36 67
andree.yeramian(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/B-5936-2009

Publications

  • Sanchez, E; Betriu, A; Yeramian, A; Fernandez, E; Purroy, F; Sanchez-de-la-Torre, M; Pamplona, R; Miquel, E; Kerkeni, M; Hernandez, C; Simo, R; Lecube, A; Hernandez, M; Rius, F; Polanco, D; Barbe, F; Torres, G; Suarez, G; Portero-Otin, M; Jove, M; Colas-Campas, L; Benabdelhak, I; Farras, C; Ortega, M; Valdivielso, JM; Bermudez-Lopez, M; Martinez-Alonso, M; ILERVAS Project

    Skin Autofluorescence Measurement n Subclinical Atheromatous Disease: Results from the ILERVAS Project

    Journal of Atherosclerosis and Thrombosis 26 879-889. .

    [doi:10.5551/jat.47498]

  • Lopez-Cano, C; Rius, F; Sanchez, E; Gaeta, AM; Betriu À; Fernandez, E; Yeramian, A; Hernandez, M; Bueno, M; Gutierrez-Carrasquilla, L; Dalmases, M; Lecube, A

    The influence of sleep apnea syndrome and intermittent hypoxia in carotid adventitial vasa vasorum

    PLOS ONE 14 -. .

    [doi:10.1371/journal.pone.0211742]

  • Rius, F; Sanchez, E; Betriu À; Baena-Fustegueras, JA; Yeramian, A; Vidal, T; Hernandez, M; Lopez-Cano, C; Bueno, M; Gutierrez-Carrasquilla, L; Herrerias, F; de la Fuente, MC; Fernandez, E; Lecube, A

    Influence of Morbid Obesity and Bariatric Surgery Impact on the Carotid Adventitial Vasa Vasorum Signal

    OBESITY SURGERY 28 3935-3942. .

    [doi:10.1007/s11695-018-3410-x]

  • Nager, M; Sallan, MC; Visa, A; Pushparaj, C; Santacana, M; Macia, A; Yeramian, A; Canti, C; Herreros, J

    Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers

    Autophagy 14 619-636. .

    [doi:10.1080/15548627.2017.1423439]

  • Eritja, N; Felip, I; Dosil, MA; Vigezzi, L; Mirantes, C; Yeramian, A; Navaridas, R; Santacana, M; Llobet-Navas, D; Yoshimura, A; Nomura, M; Encinas, M; Matias-Guiu, X; Dolcet, X

    A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-beta in mouse endometrium

    CELL DEATH AND DIFFERENTIATION 24 1443-1458. .

    [doi:10.1038/cdd.2017.73]

  • Eritja, N; Chen, BJ; Rodriguez-Barrueco, R; Santacana, M; Gatius, S; Vidal, A; Marti, MD; Ponce, J; Bergada, L; Yeramian, A; Encinas, M; Ribera, J; Reventos, J; Boyd, J; Villanueva, A; Matias-Guiu, X; Dolcet, X; Llobet-Navas, D

    Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer

    Autophagy 13 608-624. .

    [doi:10.1080/15548627.2016.1271512]

  • Eritja, N; Yeramian, A; Chen, BJ; Llobet-Navas, D; Ortega, E; Colas, E; Abal, M; Dolcet, X; Reventos, J; Matias-Guiu, X

    Endometrial Carcinoma: Specific Targeted Pathways

    Advances in Experimental Medicine and Biology 943 149-207. .

    [doi:10.1007/978-3-319-43139-0_6]

  • Jonsson, M; Ragnum, HB; Julin, CH; Yeramian, A; Clancy, T; Frikstad, KAM; Seierstad, T; Stokke, T; Matias-Guiu, X; Ree, AH; Flatmark, K; Lyng, H

    Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition

    BRITISH JOURNAL OF CANCER 115 929-939. .

    [doi:10.1038/bjc.2016.278]

  • Jove, M; Gatius, S; Yeramian, A; Portero-Otin, M; Eritja, N; Santacana, M; Colas, E; Ruiz, M; Pamplona, R; Matias-Guiu, X

    Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

    Oncotarget 7 52364-52374. .

    [doi:10.18632/oncotarget.10564]

  • Yeramian A; García V; Bergadà L; Domingo M; Santacana M; Valls J; Martinez-Alonso M; Carceller JA; Cussac AL; Dolcet X; Matias-Guiu X

    Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-kappa B Pathway in Endometrial Cancer

    MOLECULAR IMAGING AND BIOLOGY 18 545-556. .

    [doi:10.1007/s11307-015-0907-8]

  • Yeramian, A; Vea, A; Benitez, S; Ribera, J; Domingo, M; Santacana, M; Martinez, M; Maiques, O; Valls, J; Dolcet, X; Vilella, R; Cabiscol, E; Matias-Guiu, X; Marti, RM

    2-phenylethynesulphonamide (PFT-) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels

    PIGMENT CELL & MELANOMA RESEARCH 29 352-371. .

    [doi:10.1111/pcmr.12472]

  • Bergadà L; Yeramian A; Sorolla A; Matias-Guiu X; Dolcet X

    Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation

    PLOS ONE 9 -. .

    [doi:10.1371/journal.pone.0092764]

Projects

  • ¿CONOCER LA PREDISPOSICION GENETICA DEL PACIENTE CON OBESIDAD AYUDA A MEJORAR LA EFICACIA DE LA CIRUGÍA BARIÁTRICA?
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • La serine/threonine protein kinase PRK1 en l'adipòcit de pacients amb diabetes (Ajut per a la recerca de la Societat Catalana d'Endocrinologia i Nutrició)
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UN DOCTOR PER LA REALITZACIO DE L'ESTUDI DE LA FUNCIO PULMONAR I LA RESPIRACIO DURANT LA NIT: DUES NOVES PREOCUPACIONS PER LA DIABETIS MELLITUS TIPUS 2.
  • ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
  • EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA
  • Alteraciones moleculares relacionados con la progresión tumoral en el cáncer de endometrio
  • MECANISMOS DE REGULACION FLIP Y LA RESPUESTA A TRAIL EN EL DESARROLLO Y PROGRESION DEL CANCER
  • Caracterización de las células neoplásicas inmaduras pluripotenciales (células madre neoplásicas) en el cáncer de endometrio. Implicaciones Patogénicas, pronósticas y terapeuticas